Isabella Orienti

Via San Donato 19/2
Bologna, 40127, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Cytotoxic and Cytostatic Effects of Nanoformulated Fenretinide on MG63 Osteosarcoma Cells.

Cytotoxic and Cytostatic Effects of Nanoformulated Fenretinide on MG63 Osteosarcoma Cells.

Journal: Pharmaceutics

Published: December 03, 2025

High-throughput in vitro drug screening and in vivo studies identify fenretinide as a brain-penetrant DMG therapeutic.

High-throughput in vitro drug screening and in vivo studies identify fenretinide as a brain-penetrant DMG therapeutic.

Journal: Neuro-oncology

Published: February 12, 2025

Antiproliferative and Morphological Effects of Fenretinide Lipid Nanosystems in Colon Adenocarcinoma Cells.

Antiproliferative and Morphological Effects of Fenretinide Lipid Nanosystems in Colon Adenocarcinoma Cells.

Journal: Pharmaceutics

Published: September 27, 2024

A nanoencapsulated oral formulation of fenretinide promotes local and metastatic breast cancer dormancy in HER2/neu transgenic mice.

A nanoencapsulated oral formulation of fenretinide promotes local and metastatic breast cancer dormancy in HER2/neu transgenic mice.

Journal: Journal of experimental & clinical cancer research : CR

Published: May 14, 2024

Validated LC-MS/MS Assay for the Quantitative Determination of Fenretinide in Plasma and Tumor and Its Application in a Pharmacokinetic Study in Mice of a Novel Oral Nanoformulation of Fenretinide.

Validated LC-MS/MS Assay for the Quantitative Determination of Fenretinide in Plasma and Tumor and Its Application in a Pharmacokinetic Study in Mice of a Novel Oral Nanoformulation of Fenretinide.

Journal: Pharmaceutics

Published: February 16, 2024

Nano-fenretinide demonstrates remarkable activity in acute promyeloid leukemia cells.

Nano-fenretinide demonstrates remarkable activity in acute promyeloid leukemia cells.

Journal: Scientific reports

Published: December 15, 2023

Naxitamab Activity in Neuroblastoma Cells Is Enhanced by Nanofenretinide and Nanospermidine.

Naxitamab Activity in Neuroblastoma Cells Is Enhanced by Nanofenretinide and Nanospermidine.

Journal: Pharmaceutics

Published: January 15, 2023

Fenretinide in Cancer and Neurological Disease: A Two-Face Janus Molecule.

Fenretinide in Cancer and Neurological Disease: A Two-Face Janus Molecule.

Journal: International journal of molecular sciences

Published: May 27, 2022

Nanospermidine in Combination with Nanofenretinide Induces Cell Death in Neuroblastoma Cell Lines.

Nanospermidine in Combination with Nanofenretinide Induces Cell Death in Neuroblastoma Cell Lines.

Journal: Pharmaceutics

Published: March 27, 2022

Fenretinide Beneficial Effects on Amyotrophic Lateral Sclerosis-associated SOD1G93A Mutant Protein Toxicity: In Vitro and In Vivo Evidences.

Fenretinide Beneficial Effects on Amyotrophic Lateral Sclerosis-associated SOD1G93A Mutant Protein Toxicity: In Vitro and In Vivo Evidences.

Journal: Neuroscience

Published: April 30, 2021

Nanomicellar Lenalidomide-Fenretinide Combination Suppresses Tumor Growth in an MYCN Amplified Neuroblastoma Tumor.

Nanomicellar Lenalidomide-Fenretinide Combination Suppresses Tumor Growth in an MYCN Amplified Neuroblastoma Tumor.

Journal: International journal of nanomedicine

Published: May 13, 2020

Pulmonary Delivery of Fenretinide: A Possible Adjuvant Treatment In COVID-19.

Pulmonary Delivery of Fenretinide: A Possible Adjuvant Treatment In COVID-19.

Journal: International journal of molecular sciences

Published: May 03, 2020

Showing 1-12 of 26

Last Updated: 09/26/2026